The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy.
Not Applicable
- Conditions
- lcerative Colitis
- Registration Number
- JPRN-UMIN000031289
- Lead Sponsor
- Showa University Koto Toyosu Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1:Inability or unwillingness of patients to give written informed consent 2:Judged unsuitable for this study by the physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1:Try to identify molecules that could correlate with endoscopic findings(UC-EIS) before treatment and at 10 weeks on therapy. 2:To test whether a novel biomarker could be used to predict mucosal healing at 1 year after treatment initiation.
- Secondary Outcome Measures
Name Time Method 1:To evaluate the correlation between the new biomarker(s) and UCDAI score at 1,4,10 weeks and 1year after treatment. 2:To evaluate the correlation between the new biomarker(s) and Matts grade at 10 weeks after treatment.